Login / Signup

Antibiotic therapy in children with community-acquired pneumonia.

Matti Korppi
Published in: Acta paediatrica (Oslo, Norway : 1992) (2021)
PubMed was reviewed on antibiotic treatment of community-acquired pneumonia (CAP) in children for the years 2011-2020, and three clinical trials in high-income and eight in low-income countries were found. Prospective studies combining laboratory and clinical findings for steering of antibiotic treatment found that five-day courses were equally effective as longer courses. No new antibiotics were launched for children's CAP during the last 10 years. Five-day courses are equally effective as 7- to 10-day courses for CAP in children. Stewardship of antibiotics needs lessening of exposure to antibiotics by better targeting their use and by shortening the lengths of antibiotic courses.
Keyphrases
  • community acquired pneumonia
  • young adults
  • clinical trial
  • stem cells
  • drug delivery
  • cancer therapy
  • mesenchymal stem cells
  • replacement therapy
  • double blind